logo
IMCAS2026:GaldermaShowcasestheLatestScientificAdvancesBehindtheIndustry’sBroadestInjectableAestheticsPortfolio
===2026/1/22 20:34:54===
ing degradation of the extracellular matrix, which results in volume loss, laxity, and the appearance of wrinkles.3,18,19,25-27Sculptra progressively rebuilds the skin’s structural foundation by encouraging the remodeling of components of the extracellular matrix, such as elastin and collagen, helping to gradually restore volume, firmness, radiance and skin quality, and the look of fullness to wrinkles and folds over time.3-7,18,19,28Sculptra has been shown to provide visible improvements as early as one month after treatment, with results lasting up to two years.3,6,23,28,29

About the Restylane portfolio
Restylane HA treatments are designed differently to go beyond volumizing for natural-looking results.30-33Our HA is minimally modified and our innovative manufacturing process preserves its biocompatibility while creating individual products designed for a specific purpose.34-37Powered by NASHA®, NASHA HD, OBT™ and SB-NASHA™ technologies, Restylane
=*=*=*=*=*=
当前为第9/21页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页